NCT02034682View on ClinicalTrials.gov

The Effect of Hydroxyethylstarch 6% 130/0.4 in a Balanced Electrolyte Solution (Volulyte®) Compared to Gelatine (Geloplasma®) on Microvascular Reactivity and Tissue Oxygen Saturation During Haemodilution Measured With Near-infrared Spectroscopy

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

April 30, 2015

Conditions

Microvascular ReactivityTissue Oxygen Saturation

Interventions

DRUG

Volulyte 6%

During elective coronary artery bypass grafting surgery, patients need to be attached to a cardiopulmonary bypass circuit. Administration of Volulyte 6% to the cardiopulmonary bypass circuit.

DRUG

Geloplasma

During elective coronary artery bypass grafting surgery, patients need to be attached to a cardiopulmonary bypass circuit. Administration of Geloplasma to the cardiopulmonary bypass circuit.

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors

lead

University Hospital, Ghent

OTHER